Sep 07, 2023 / 02:30PM GMT
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director and SMid Cap Biotech Analyst
(technical difficulty)
with a fireside chat with Karuna. I'm Yigal Nochomovitz, I'm one of the biotech analysts at Citi. It's my pleasure to have with me Andrew Miller, who's one of the founders and the COO of the company.
Welcome, Andrew. Thank you so much for taking the time.
Andrew Craig Miller - Karuna Therapeutics, Inc. - Co-Founder & COO
Yes, great. It's great to be here. Thanks for having us.
Questions and Answers:
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director and SMid Cap Biotech AnalystSo maybe let's just start out with just a quick 2-minute overview of the company. What are the programs? What are some of the key timelines, and then we can dig into KarXT, the mechanism and some of the details?
Andrew Craig Miller - Karuna Therapeutics, Inc. - Co-Founder & COO
Yes, absolutely. So at Karuna, we're focused on
Trustpilot
